Search

Your search keyword '"Kamensky, G"' showing total 76 results

Search Constraints

Start Over You searched for: Author "Kamensky, G" Remove constraint Author: "Kamensky, G"
76 results on '"Kamensky, G"'

Search Results

2. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

3. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

4. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

5. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

6. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

7. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

8. Treatment efficiency of resistant hypertension in cardiologist’s office

9. Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

11. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

12. Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry

13. The long-term multicenter observational study of dabigatran treatment in patients with atrial fibrillation (RELY-ABLE) study

14. European National Society cardiovascular journals. Background, rationale and mission statement of the 'Editors' Club' (Task Force of the European Society of Cardiology)

16. The long-term multicenter observational study of dabigatran treatment in patients with atrial fibrillation (RELY-ABLE) study

17. The role of European national journals in education

21. Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial.

24. European national society cardiovascular journals background, rationale and mission statement of the 'Editors' Club' (Task Force of the European Society of Cardiology) | Revistas cardiovasculares de las sociedades nacionales europeas. Antecedentes, fundamento y declaración de objetivos del 'Club de Editores' (Grupo de trabajo de la Sociedad Europea de Cardiologia)

25. The role of European national journals in medical education,El papel de las revistas nacionales europeas en la formación médica

26. The role of European National Journals in education

27. European national society cardiovascular journals background, rationale and mission statement of the 'Editors' Club' (Task Force of the European Society of Cardiology),Revistas cardiovasculares de las sociedades nacionales europeas. Antecedentes, fundamento y declaración de objetivos del 'Club de Editores' (Grupo de trabajo de la Sociedad Europea de Cardiologia)

28. European National Society Cardiovascular Journals: Background, rationale and mission statement of the 'editors' club' (Task Force of the European Society of Cardiology)

29. The role of European national journals in education | Rola europejskich czasopism narodowych w edukacji

30. Cardiovascular journals of national societies in Europe. Background, rationale and mission statement of 'Editors' Club' | Revistas cardiovasculares de las sociedades nacionales europeas. antecedentes, fundamento y declaración de objetivos del 'club de editores'

31. European National Society Cardiovascular Journals. Background, rationale and mission statement of the 'Editors' Club' (Task Force of the European Society of Cardiology)

32. European national society cardiovascular journals. Background, rationale and mission statement of the «editors¿ club» | Revistas cardiovasculares de las sociedades nacionales europeas. Antecedentes, fundamento y declaración de objetivos del «Club de editores»

33. The role of European National Journals in Education

34. European National Society Cardiovascular Journals. Background, rationale and mission statement of the 'Editors' Club'

35. The role of European national journals in education | Die rolle der Europäischen nationalen journale in der fortbildung

36. The role of European national journals in education,Rola europejskich czasopism narodowych w edukacji

37. European national society cardiovascular journals. Background, rationale and mission statement of the «editors¿ club»,Revistas cardiovasculares de las sociedades nacionales europeas. Antecedentes, fundamento y declaración de objetivos del «Club de editores»

38. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)

39. European National Society Cardiovascular Journals. Background, rationale and mission statement of the 'Editors' Club' (Task Force of the European Society of Cardiology)

40. European national society cardiovascular journals. Background, rationale and mission statement of the 'editors' club' (Task force of the European society of cardiology)

41. Cardiovascular journals of national societies in Europe. Background, rationale and mission statement of 'Editors' Club',Revistas cardiovasculares de las sociedades nacionales europeas. antecedentes, fundamento y declaración de objetivos del 'club de editores'

42. Antiinflammatory therapy with canakinumab for atherosclerotic disease

44. Rosuvastatin in older patients with systolic heart failure.

45. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

46. Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction.

47. Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.

48. Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54.

49. Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54.

50. Predictors of blood pressure control in patients with resistant hypertension.

Catalog

Books, media, physical & digital resources